Diabetes News and Research

Latest Diabetes News and Research

Carrot fiber supplement boosts gut bacteria and immune defenses

This trial reveals that carrot-derived rhamnogalacturonan-I boosts Bifidobacteria and supports immune function, highlighting its potential for gut health.

18 Sep 2025

Scientists unveil new obesity drug that reprograms fat and energy use

Details of a new drug that aims to treat the underlying causes of obesity are being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September).

18 Sep 2025

Type 2 diabetes accelerates accumulation of chronic diseases across age groups

New research being presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Vienna (15-19 Sept), reveals type 2 diabetes (T2D) as a critical factor in chronic disease accumulation, particularly during the early stages.

17 Sep 2025

Psoriasis linked to higher risk of age-related macular degeneration

New research presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2025 reveals that people with psoriasis face a significantly increased risk of developing age-related macular degeneration (AMD), a leading cause of vision loss.

17 Sep 2025

GLP-1RAs linked to lower risk of mortality and cardiovascular events in psoriasis patients

Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% lower risk of major cardiovascular events compared to those taking other diabetes or weight-loss medications, new research has shown.

17 Sep 2025

Tai chi improves memory and sleep in older adults with type 2 diabetes

A 12-week randomized trial found that remotely delivered Tai Chi significantly enhanced cognitive performance and sleep quality in older adults with Type 2 Diabetes. These gains surpassed those from supervised fitness walking or usual care, without increasing adverse events.

17 Sep 2025

High fat diet impairs memory formation through autophagy dysfunction

Modern lifestyles and dietary changes have significantly increased the consumption of high-fat foods, contributing to a steep rise in the prevalence of obesity, diabetes, and metabolic disorders.

17 Sep 2025

Projected surge in uninsured will strain local health systems

Jake Margo Jr. stood in the triage room at Starr County Memorial Hospital explaining why a person with persistent fever who could be treated with over-the-counter medication didn't need to be admitted to the emergency room.

17 Sep 2025

Watching more than 4 hours of TV daily raises the risk of cognitive decline

This study finds a link between long TV viewing and cognitive impairment, stressing the importance of addressing sedentary lifestyles for dementia prevention.

17 Sep 2025

New EASD guideline combines clinical standards with lived experience

The guideline was developed in line with internationally recognized standards, including the GRADE methodology and the RIGHT reporting statement, and reflects the EASD's newly established Standard Operating Procedures for guideline development.

17 Sep 2025

A new tool in the fight against obesity: Orforglipron's substantial weight loss results

New research presented at the Annual Meeting of the European Association for the Study of Diabetes in Vienna, Austria (Sept 15-19) and simultaneously published in NEJM shows that daily treatment with the new once-daily GLP-1 agonist orforglipron results in substantial weight loss in people living with obesity that do not have type 2 diabetes.

17 Sep 2025

GLP-1 drugs found to protect against diabetic retinopathy

GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight loss, suggests new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) and published in the journal Pharmaceutics.

17 Sep 2025

The mind-gut connection: How emotional eating affects GLP-1 drug success

GLP-1 receptor agonists like Ozempic can be a lifeline for people with diabetes - helping stabilize blood glucose and lose weight which contributes to diabetes complications. But not everyone benefits equally.

17 Sep 2025

Exercise found to reduce artery hardening after weight loss in adults with obesity

Maintaining weight loss with regular exercise rather than the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide, a drug used to treat type 2 diabetes and obesity, seems to reduce atherosclerosis development in adults with obesity-a leading underlying cause of cardiovascular disease.

17 Sep 2025

Common bladder infection may signal urogenital cancer risk

A bout of the common bladder infection, cystitis, may signal the presence of urogenital cancers-which affect parts of the body involved in reproduction and excretion-in middle aged adults, suggests research published in the open access journal BMJ Public Health.

17 Sep 2025

Healthy plant-based diet may lower type 2 diabetes risk while reducing greenhouse gas emissions

A diet focused on healthy plant-based foods may lower the risk of type 2 diabetes while reducing greenhouse gas emissions, according to a new study by Solomon Sowah and colleagues from the MRC Epidemiology Unit at the University of Cambridge, United Kingdom, published September 16th in the open-access journal PLOS Medicine.

16 Sep 2025

Uterine corpus malignancies with pregnancy-like features lead to poor survival outcomes

A new review was published in Volume 12 of Oncoscience on September 4, 2025, titled "Prognostic significance of trophoblastic differentiation and β-hCG secretion in somatic malignancies of uterine corpus: A systematic review with survival analysis."

16 Sep 2025

Researchers provide new insights into how exercise helps lose weight

Researchers at Baylor College of Medicine, Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children's Hospital, Stanford University School of Medicine and collaborating institutions provide new insights into how exercise helps lose weight.

16 Sep 2025

Lifestyle changes show promise in preventing cognitive decline and Alzheimer’s disease

An estimated 7.2 million Americans over age 65 currently live with Alzheimer's disease (AD). That number is expected to nearly double to 13.8 million by 2060.

16 Sep 2025

Higher-dose semaglutide helps people lose nearly 19% of body weight

The STEP UP trial reveals semaglutide 7.2 mg significantly reduces weight compared to 2.4 mg, though it raises questions about gastrointestinal side effects.

16 Sep 2025

Previous
1
...
5
6
7
8
9
10
11
...
1913
Next

Diabetes News and Research

Latest Diabetes News and Research

Carrot fiber supplement boosts gut bacteria and immune defenses

Scientists unveil new obesity drug that reprograms fat and energy use

Type 2 diabetes accelerates accumulation of chronic diseases across age groups

Psoriasis linked to higher risk of age-related macular degeneration

GLP-1RAs linked to lower risk of mortality and cardiovascular events in psoriasis patients

Tai chi improves memory and sleep in older adults with type 2 diabetes

High fat diet impairs memory formation through autophagy dysfunction

Projected surge in uninsured will strain local health systems

Watching more than 4 hours of TV daily raises the risk of cognitive decline

New EASD guideline combines clinical standards with lived experience

A new tool in the fight against obesity: Orforglipron's substantial weight loss results

GLP-1 drugs found to protect against diabetic retinopathy

The mind-gut connection: How emotional eating affects GLP-1 drug success

Exercise found to reduce artery hardening after weight loss in adults with obesity

Common bladder infection may signal urogenital cancer risk

Healthy plant-based diet may lower type 2 diabetes risk while reducing greenhouse gas emissions

Uterine corpus malignancies with pregnancy-like features lead to poor survival outcomes

Researchers provide new insights into how exercise helps lose weight

Lifestyle changes show promise in preventing cognitive decline and Alzheimer’s disease

Higher-dose semaglutide helps people lose nearly 19% of body weight

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Diabetes News and Research

Latest Diabetes News and Research

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in